From: Cancer vaccines as promising immuno-therapeutics: platforms and current progress
NCT number | Status | Targeted antigens/biological | Conditions | Phases | Category |
---|---|---|---|---|---|
NCT03136406 | Active, not recruiting | mutant KRAS | Pancreatic Cancer | I/II | Virus vector |
NCT03329248 | Active, not recruiting | ALT-803, ETBX-011, GI-4000 | Pancreatic Cancer | I/II | Virus vector |
NCT03632941 | Recruiting | HER2 | Breast Cancer | II | Virus vector |
NCT04410874 | Recruiting | MUSIC-01 | Non-melanoma Skin Cancer, Squamous /Basal Cell Carcinoma | I/II | Virus vector |
NCT04432597 | Recruiting | PRGN-2009 | HPV-associated Cancers | I/II | Virus vector |
NCT03815942 | Active, not recruiting | ChAdOx1-MVA 5T4 | Prostate Cancer | I/II | Virus vector |
NCT03547999 | Active, not recruiting | MVA-BN-CV301 | Metastatic Colorectal Cancer | II | Virus vector |
NCT03113487 | Recruiting | p53 | Recurrent Ovarian, Primary Peritoneal, Fallopian Tube Cancer | II | Virus vector |
NCT04111172 | Recruiting | Ad5.F35-hGCC-PADRE | Gastrointestinal Adenocarcinoma | II | Virus vector |
NCT03315871 | Recruiting | PROSTVAC-V/F, CV301 | Prostate Cancer | II | Virus vector |
NCT04574583 | Active, not recruiting | MVA-BN-CV301 | Metastatic Cancer, Solid Tumors | I/II | Virus vector |
NCT02649855 | Active, not recruiting | PROSTVAC-F/V | Prostate Cancer, Prostate Neoplasms, Neoplasms, Prostatic | II | Virus vector |
NCT02933255 | Recruiting | PROSTVAC-V/F | Prostate Cancer | I/II | Virus vector |
NCT03563157 | Active, not recruiting | MUC1, HER2, IL-15 | Colorectal Cancer Metastatic, mCRC | I/II | Virus vector |
NCT03953235 | Recruiting | Neoantigens | Non-Small Cell Lung Cancer, Colorectal Cancer, Pancreatic Cancer, Solid Tumor | I/II | Virus vector/mRNA |